Russell Investments Group
MRVI icon

Russell Investments Group’s Maravai LifeSciences MRVI Stock Holding History

Russell Investments Group’s Portfolio MRVI Stock Details MRVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$989K Buy
158,544
+19,801
+14% +$85.5K ﹤0.01% 2469
2026
Q1 		$393K Buy
138,743
+6,002
+5% +$20.3K ﹤0.01% 2598
2025
Q4 		$431K Buy
132,741
+20,434
+18% +$68.8K ﹤0.01% 2543
2025
Q3 		$322K Buy
112,307
+71,961
+178% +$184K ﹤0.01% 2640
2025
Q2 		$97.2K Sell
40,346
-304
-0.7% -$639 ﹤0.01% 2821
2025
Q1 		$89.8K Buy
+40,650
New +$161K ﹤0.01% 2781
2024
Q3 		– Sell
-1,577
Closed -$11.3K – 3755
2024
Q2 		$11.3K Sell
1,577
-11,604
-88% -$100K ﹤0.01% 3046
2024
Q1 		$114K Sell
13,181
-99,415
-88% -$673K ﹤0.01% 2556
2023
Q4 		$738K Buy
112,596
+112,417
+62,803% +$726K ﹤0.01% 2089
2023
Q3 		$1.79K Buy
179
+153
+588% +$1.68K ﹤0.01% 3274
2023
Q2 		$323 Sell
26
-2,800
-99% -$37.8K ﹤0.01% 3389
2023
Q1 		$39.6K Sell
2,826
-20,959
-88% -$301K ﹤0.01% 2739
2022
Q4 		$340K Buy
+23,785
New +$375K ﹤0.01% 2427

Other funds holding MRVI

GL
GTCR LLC Chicago, Illinois $3.91B AUM 14.64% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
1WCM
12 West Capital Management New York $535M AUM 25.99% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OAM
Ophir Asset Management Sydney, Australia $1.22B AUM 100.03% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return

Russell Investments Group's MRVI Position: Q2 2026 in Review

Russell Investments Group increased its Maravai LifeSciences (MRVI) stake by 14% in Q2 2026, buying an estimated $85.5K and bringing the position to 158,544 shares worth $989K. The position accounts for ﹤0.01% of the portfolio, ranked #2469.

Russell Investments Group first reported a position in MRVI in Q4 2022 and has held it in 13 quarters since. 178 funds tracked by Wall St. Rank hold MRVI as of Q2 2026.

  • Russell Investments Group held 158,544 shares of Maravai LifeSciences worth $989K as of Q2 2026.
  • Russell Investments Group bought 19,801 Maravai LifeSciences shares in Q2 2026, an estimated $85.5K.
  • Maravai LifeSciences made up ﹤0.01% of Russell Investments Group's portfolio in Q2 2026, its #2469 holding.
  • Russell Investments Group first reported a position in Maravai LifeSciences in Q4 2022 and has held it in 13 quarters since.
  • 178 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q2 2026.

Based on Russell Investments Group's 13F filing for Q2 2026, filed 6 Aug 2026.